Claims for Patent: 5,240,734
✉ Email this page to a colleague
Summary for Patent: 5,240,734
| Title: | Reduced-fat peanut butter compositions and methods for preparing same |
| Abstract: | A composition and method of making a reduced fat peanut butter in the form of a water-in-oil emulsion which contains a continuous peanut butter oil phase of peanut butter, and a protein complexing agent to maintain the consistency of the continuous peanut butter oil phase, and a discontinuous aqueous coagulated protein phase to reduce the fat content of the peanut butter which contains a coagulable dairy or vegetable protein and a protein coagulating agent. |
| Inventor(s): | Izzo; Henry J. (Bridgewater, NJ), Lieberman; Robert E. (Morris Township, Morris County, NJ) |
| Assignee: | Healthy Foods Solutions (Morris Township, Morris County, NJ) |
| Application Number: | 07/708,484 |
| Patent Claims: | 1. A reduced-fat peanut butter composition in the form of a water-in-oil emulsion which comprises:
(A) a continuous peanut butter oil phase which comprises: (a) peanut butter; and (b) an effective amount of a protein complexing agent to maintain the consistency of the continuous peanut butter oil phase; and (B) a discontinuous aqueous coagulated protein phase to reduce the fat content of the peanut butter present in the reduced-fat peanut butter composition in an amount from about 10% to about 90% by weight, which comprises: (a) a coagulable dairy and vegetable protein selected from the group consisting of milk protein, egg protein, soy bean protein, and peanut protein present in the discontinuous aqueous coagulated protein phase in an amount from about 1% to about 5% by weight; and (b) a protein coagulating agent. 2. The peanut butter composition according to claim 1, wherein the discontinuous aqueous coagulated protein phase is a premixed phase. 3. The peanut butter composition according to claim 1, wherein the coagulable protein is milk protein. 4. The peanut butter composition according to claim 1, wherein the protein coagulating agent is a protein coagulating enzyme selected from the group consisting of rennin, Mucor miehei, Mucor pusillus, Endothia parasitica, porcine pepsin, and mixtures thereof. 5. The peanut butter composition according to claim 1, wherein the protein complexing agent is selectable from the group consisting of non-toxic water-soluble calcium compounds and magnesium compounds. 6. The peanut butter composition according to claim 5, wherein the protein coagulating enzyme is present in the discontinuous aqueous coagulated protein phase in an amount from about 0.01% to about 1.2%, by weight of the discontinuous aqueous coagulated protein phase. 7. The peanut butter composition according to claim 1, wherein the protein complexing agent is present in the continuous peanut butter oil phase in an amount from about 0.1% to about 1.5%, by weight of the continuous peanut butter oil phase. 8. The peanut butter composition according to claim 1, wherein the discontinuous aqueous coagulated protein phase further comprises sufficient water-soluble solids to yield a water activity in the range from about 0.65 to about 0.99 and a water-soluble solids value from about 55% to about 72% by weight of the discontinuous aqueous coagulated protein phase. 9. The peanut butter composition according to claim 1, wherein the discontinuous aqueous coagulated protein phase further comprises a chelating agent present in an amount from about 0.01% to about 1.5%, by weight of the discontinuous aqueous coagulated protein phase. 10. An edible composition which comprises an edible carrier and a reduced-fat peanut butter composition in the form of a water-in-oil emulsion, wherein the peanut butter composition comprises: (A) a continuous peanut butter oil phase which comprises: (a) peanut butter: and (b) an effective amount of a protein complexing agent to maintain the consistency of the continuous peanut butter oil phase; and (B) a discontinuous aqueous coagulated protein phase to reduce the fat content of the peanut butter present in the reduced-fat peanut butter composition in an amount from about 10% to about 90%, by weight, which comprises: (a) a coagulable dairy and vegetable protein selected from the group consisting of milk protein, egg protein, soy bean protein, and peanut protein present in the discontinuous aqueous coagulated protein phase in an amount from about 1% to about 5%, by weight; and (b) a protein coagulating agent. 11. The edible composition according to claim 10, wherein the discontinuous aqueous coagulated protein phase is a premixed phase. 12. The edible composition according to claim 10, wherein the coagulable protein is milk protein 13. The edible composition according to claim 10, wherein the protein coagulating agent is a protein coagulating enzyme selected from the group consisting of rennin, Mucor miehei, Mucor pusillus, Endothia parasitica, porcine pepsin, and mixtures thereof. 14. The edible composition according to claim 10, wherein the protein complexing agent is selected from the group consisting of non-toxic water-soluble calcium compounds and magnesium compounds. 15. The edible composition according to claim 10, wherein the reduced-fat peanut butter composition is present in the edible composition in an amount up to about 90%, by weight of the edible composition. 16. A method for preparing reduced-fat peanut butter composition in the form of a water-in-oil emulsion which comprises the steps of: (1) providing the following ingredients: (A) a continuous peanut butter oil phase which comprises peanut butter; and (B) a discontinuous aqueous coagulated protein phase to reduce the fat content of the peanut butter present in the reduced-fat peanut butter composition in an amount from about 10% to about 90%, by weight, which comprises: (a) a coagulable dairy and vegetable selected from the group proteins consisting of milk protein, egg protein, soy bean protein, and peanut protein present in the discontinuous aqueous coagulated protein phase in an amount from about 1% to about 5%, by weight; (b) a protein coagulated agent; and (c) an effective amount of a protein complexing agent to maintain the consistency of the continuous peanut butter oil phase; (2) admixing the peanut butter oil phase and the aqueous protein phase to form a reduced-fat peanut butter composition in the form of an water-in-oil emulsion having a continuous peanut butter oil phase and a discontinuous aqueous coagulated protein phase. 17. The method according to claim 16, wherein the aqueous protein phase from step (1)(B) is premixed before step (2). 18. A reduced-fat peanut butter composition in the form of a water-in-oil emulsion prepared by a method which comprises the steps of: (1) providing the following ingredients: (A) a continuous peanut butter oil phase which comprises peanut butter; and (B) a discontinuous aqueous coagulated protein phase to reduce the fat content of the peanut butter present in the reduced-fat peanut butter composition in an amount from about 10% to about 90%, by weight, which comprises: (a) a coagulable dairy and vegetable protein selected from the group consisting of milk protein, egg protein, soy bean protein, and peanut protein present in the discontinuous aqueous coagulated protein phase in an amount from about 1% to about 5%, by weight: (b) a protein coagulated agent; and (c) an effective amount of a protein complexing agent to maintain the consistency of the continuous peanut butter oil phase; (2) admixing the peanut butter oil phase and the aqueous protein phase to form a reduced-fat peanut butter composition in the form of an water-in-oil emulsion having a continuous peanut butter oil phase and a discontinuous aqueous coagulated protein phase. 19. The reduced-fat peanut butter composition according to claim 18, wherein the aqueous protein phase from step (1)(B) is premixed before step (2). 20. A peanut butter composition in the form of a water-in-oil emulsion which comprises: (A) a continuous peanut butter oil phase which comprises: (a) peanut butter; and (b) an effective amount of a protein complexing agent to maintaining the consistency of the continuous peanut butter oil phase; and (B) a discontinuous aqueous phase present in the peanut butter composition in an amount from about 10% to about 90%, by weight, which comprises an effective amount of water-soluble solids to yield a water activity in the range from about 0.65 to about 0.99 and a water-soluble solids value from about 55% to about 72%, by weight of the discontinuous aqueous phase. |
Details for Patent 5,240,734
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Aimmune Therapeutics, Inc. | PALFORZIA | peanut (arachis hypogaea) allergen powder-dnfp | Powder | 125696 | January 31, 2020 | ⤷ Get Started Free | 2011-05-31 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
